The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Vicks DayQuil-D COLD and SINUS plus SEVERE CONGESTION
Acetaminophen, Guaifenesin, Pseudoephedrine HCl, Dextromethorphan HBr · ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1; GUAIFENESIN 200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 30 mg/1 · Capsule, Liquid Filled · Oral · The Procter & Gamble Manufacturing Company
NDC 84126-0363-12 · 12 CAPSULE, LIQUID FILLED in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for acetaminophen, guaifenesin, pseudoephedrine hcl, dextromethorphan hbr (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Opioid Analgesic REMS Shared System REMS
Regulatory
- Application
- M012
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Acetaminophen, Guaifenesin, Pseudoephedrine HCl, Dextromethorphan HBr (Capsule, Liquid Filled)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Patheon Softgels Inc. | PSEUDOEPHEDRINE HYDROCHLORIDE 30 mg/1; GUAIFENESIN 200 mg/1; ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1 | Aug 20, 2026 | Sep 3, 2026 |
| The Procter & Gamble Manufacturing Company | ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1; GUAIFENESIN 200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Patheon Softgels Inc. | PSEUDOEPHEDRINE HYDROCHLORIDE 325 mg/1; GUAIFENESIN 10 mg/1; ACETAMINOPHEN 200 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 30 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| Patheon Softgels Inc. | ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/1; GUAIFENESIN 200 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 30 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Vicks DayQuil-D COLD and SINUS plus SEVERE CONGESTION — NDC 84126-0363-12," retrieved September 3, 2026, https://drugdashboards.com/drug/84126036312.
Free to cite with attribution — see how the data is put together.